Image center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Medicine (Baltimore). 2022 Aug 26;101(34):e30031. doi: 10.1097/MD.0000000000030031.
Because sarcopenia is widely distributed in patients with acute ischemic stroke (AIS) and has not attracted enough attention, this study aims to explore the relationship between sarcopenia defined by temporal muscle thickness (TMT) and physical function and prognosis of patients with AIS. A total of 265 hospitalized nonsurgical AIS patients from 2015 to 2018, with an age range of 28 ~ 92, were analyzed retrospectively. The median value of TMT was used as the risk classification index of sarcopenia. The main results were the relationship between sarcopenia and Essen Stroke Risk Score, National Institutes of Health Stroke Scale, modified Rankin Score, water swallow test, venous thromboembolism assessment of medical inpatients, activities of daily living assessed by Barthel Index, and the relationship between TMT and final survival outcome. The mean TMT of men in the study cohort was higher than that of women. The measured values of TMT among different researchers had good consistency (intraclass correlation coefficient, 0.980; P < .001). After adjusting for confounding variables, logistic regression showed that sarcopenia was associated with Essen Stroke Risk Score (odds ratio, 1.89; P < .05) and Barthel Index (odds ratio, 1.67; P < .05). Kaplan-Meier analysis showed that the survival time of low TMT group was significantly lower than that of high TMT group (36 vs 49 months; P < .001). Multivariate Cox regression showed that there was causal correlation between sarcopenia and patient death (hazard ratio, 3.54; 95% confidence interval, 1.46-8.58; P < .01). As a potential comprehensive index, thickness of temporal muscle can be included in baseline evaluation to show the physical status, stroke recurrence, and survival prognosis of AIS patients.
由于骨骼肌减少症在急性缺血性脑卒中(AIS)患者中广泛存在但尚未引起足够重视,本研究旨在探讨以颞肌厚度(TMT)定义的骨骼肌减少症与 AIS 患者的身体功能和预后之间的关系。回顾性分析了 2015 年至 2018 年期间 265 名住院非手术 AIS 患者,年龄 28~92 岁。以 TMT 的中位数作为骨骼肌减少症的风险分类指标。主要结果是骨骼肌减少症与 Essen 卒中风险评分、美国国立卫生研究院卒中量表、改良 Rankin 评分、饮水试验、住院患者静脉血栓栓塞评估、日常生活活动能力(Barthel 指数评估)之间的关系,以及 TMT 与最终生存结局之间的关系。研究队列中男性的平均 TMT 高于女性。不同研究人员测量的 TMT 值具有良好的一致性(组内相关系数 0.980;P <.001)。在调整混杂变量后,Logistic 回归显示,骨骼肌减少症与 Essen 卒中风险评分(优势比 1.89;P <.05)和 Barthel 指数(优势比 1.67;P <.05)相关。Kaplan-Meier 分析显示,TMT 低组的生存时间明显低于 TMT 高组(36 个月比 49 个月;P <.001)。多变量 Cox 回归显示,骨骼肌减少症与患者死亡之间存在因果关系(风险比 3.54;95%置信区间 1.46-8.58;P <.01)。作为一个潜在的综合指标,颞肌厚度可以包含在基线评估中,以显示 AIS 患者的身体状况、卒中复发和生存预后。